Catherine Novack
Stock Analyst at Jones Trading
(2.08)
# 3,023
Out of 5,182 analysts
24
Total ratings
25%
Success rate
4.45%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Novack
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IBIO iBio, Inc. | Initiates: Buy | $7 | $2.10 | +233.33% | 1 | Mar 3, 2026 | |
| SEPN Septerna | Initiates: Buy | $43 | $25.93 | +65.83% | 1 | Dec 23, 2025 | |
| KRRO Korro Bio | Downgrades: Hold | n/a | $13.68 | - | 2 | Nov 14, 2025 | |
| AARD Aardvark Therapeutics | Initiates: Buy | $33 | $5.08 | +549.61% | 1 | Oct 1, 2025 | |
| DYN Dyne Therapeutics | Initiates: Buy | $30 | $19.98 | +50.15% | 1 | Jun 26, 2025 | |
| CAPR Capricor Therapeutics | Maintains: Buy | $40 → $29 | $35.04 | -17.24% | 2 | Jun 25, 2025 | |
| FEMY Femasys | Maintains: Buy | $10 → $6 | $0.43 | +1,298.60% | 2 | May 13, 2025 | |
| RLYB Rallybio | Downgrades: Hold | n/a | $8.28 | - | 1 | Apr 15, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $45 | $128.63 | -65.02% | 1 | Mar 25, 2025 | |
| PRQR ProQR Therapeutics | Initiates: Buy | $11 | $1.99 | +452.76% | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.05 | - | 1 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $16 | $7.59 | +110.80% | 2 | Sep 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $4.83 | +189.86% | 1 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $13 | $1.79 | +626.26% | 2 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $3.59 | +178.55% | 1 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $0.64 | +3,364.02% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $7.38 | - | 2 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,600 | $4.11 | +38,829.44% | 1 | Jul 21, 2023 |
iBio, Inc.
Mar 3, 2026
Initiates: Buy
Price Target: $7
Current: $2.10
Upside: +233.33%
Septerna
Dec 23, 2025
Initiates: Buy
Price Target: $43
Current: $25.93
Upside: +65.83%
Korro Bio
Nov 14, 2025
Downgrades: Hold
Price Target: n/a
Current: $13.68
Upside: -
Aardvark Therapeutics
Oct 1, 2025
Initiates: Buy
Price Target: $33
Current: $5.08
Upside: +549.61%
Dyne Therapeutics
Jun 26, 2025
Initiates: Buy
Price Target: $30
Current: $19.98
Upside: +50.15%
Capricor Therapeutics
Jun 25, 2025
Maintains: Buy
Price Target: $40 → $29
Current: $35.04
Upside: -17.24%
Femasys
May 13, 2025
Maintains: Buy
Price Target: $10 → $6
Current: $0.43
Upside: +1,298.60%
Rallybio
Apr 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $8.28
Upside: -
Palvella Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $45
Current: $128.63
Upside: -65.02%
ProQR Therapeutics
Feb 12, 2025
Initiates: Buy
Price Target: $11
Current: $1.99
Upside: +452.76%
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.05
Upside: -
Sep 25, 2024
Maintains: Buy
Price Target: $12 → $16
Current: $7.59
Upside: +110.80%
Sep 12, 2024
Initiates: Buy
Price Target: $14
Current: $4.83
Upside: +189.86%
Aug 16, 2024
Maintains: Buy
Price Target: $5 → $13
Current: $1.79
Upside: +626.26%
Apr 18, 2024
Initiates: Buy
Price Target: $10
Current: $3.59
Upside: +178.55%
Feb 16, 2024
Initiates: Buy
Price Target: $22
Current: $0.64
Upside: +3,364.02%
Oct 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $7.38
Upside: -
Jul 21, 2023
Initiates: Buy
Price Target: $1,600
Current: $4.11
Upside: +38,829.44%